Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN vs STRIDES PHARMA SCIENCE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN STRIDES PHARMA SCIENCE LUPIN/
STRIDES PHARMA SCIENCE
 
P/E (TTM) x 40.7 -1,455.3 - View Chart
P/BV x 6.0 3.3 182.5% View Chart
Dividend Yield % 0.2 0.2 129.0%  

Financials

 LUPIN   STRIDES PHARMA SCIENCE
EQUITY SHARE DATA
    LUPIN
Mar-23
STRIDES PHARMA SCIENCE
Mar-23
LUPIN/
STRIDES PHARMA SCIENCE
5-Yr Chart
Click to enlarge
High Rs799392 203.7%   
Low Rs583263 221.3%   
Sales per share (Unadj.) Rs365.8408.5 89.5%  
Earnings per share (Unadj.) Rs9.8-25.6 -38.5%  
Cash flow per share (Unadj.) Rs29.21.4 2,134.3%  
Dividends per share (Unadj.) Rs4.001.50 266.7%  
Avg Dividend yield %0.60.5 126.5%  
Book value per share (Unadj.) Rs270.7242.8 111.5%  
Shares outstanding (eoy) m454.9890.30 503.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.90.8 235.4%   
Avg P/E ratio x70.2-12.8 -547.7%  
P/CF ratio (eoy) x23.7239.6 9.9%  
Price / Book Value ratio x2.61.4 189.1%  
Dividend payout %40.7-5.9 -693.0%   
Avg Mkt Cap Rs m314,38129,603 1,062.0%   
No. of employees `000NANA-   
Total wages/salary Rs m30,8727,320 421.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m166,41736,884 451.2%  
Other income Rs m1,5091,352 111.6%   
Total revenues Rs m167,92638,236 439.2%   
Gross profit Rs m17,206830 2,073.5%  
Depreciation Rs m8,8072,433 362.0%   
Interest Rs m2,7432,611 105.0%   
Profit before tax Rs m7,165-2,862 -250.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,688-553 -486.1%   
Profit after tax Rs m4,477-2,309 -193.9%  
Gross profit margin %10.32.2 459.6%  
Effective tax rate %37.519.3 194.2%   
Net profit margin %2.7-6.3 -43.0%  
BALANCE SHEET DATA
Current assets Rs m124,51331,353 397.1%   
Current liabilities Rs m92,65429,902 309.9%   
Net working cap to sales %19.13.9 486.8%  
Current ratio x1.31.0 128.2%  
Inventory Days Days2671 36.9%  
Debtors Days Days98129 76.4%  
Net fixed assets Rs m103,49031,300 330.6%   
Share capital Rs m910903 100.8%   
"Free" reserves Rs m122,24621,025 581.4%   
Net worth Rs m123,15621,928 561.6%   
Long term debt Rs m27511,398 2.4%   
Total assets Rs m228,00363,734 357.7%  
Interest coverage x3.6-0.1 -3,764.3%   
Debt to equity ratio x00.5 0.4%  
Sales to assets ratio x0.70.6 126.1%   
Return on assets %3.20.5 667.3%  
Return on equity %3.6-10.5 -34.5%  
Return on capital %8.0-0.8 -1,067.6%  
Exports to sales %046.7 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA17,213 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m48,05718,113 265.3%   
Fx outflow Rs m21,752672 3,239.1%   
Net fx Rs m26,30617,442 150.8%   
CASH FLOW
From Operations Rs m18,972444 4,272.0%  
From Investments Rs m-12,8683,025 -425.4%  
From Financial Activity Rs m-3,373-2,139 157.7%  
Net Cashflow Rs m2,7321,328 205.8%  

Share Holding

Indian Promoters % 46.8 27.4 170.7%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 45.8 38.9 118.0%  
FIIs % 16.1 19.5 82.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 53.0 72.6 72.9%  
Shareholders   281,542 91,182 308.8%  
Pledged promoter(s) holding % 0.0 69.2 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Lupin vs STRIDES PHARMA SCIENCE

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Lupin vs STRIDES PHARMA SCIENCE Share Price Performance

Period Lupin STRIDES PHARMA SCIENCE S&P BSE HEALTHCARE
1-Day 1.23% 1.16% 1.18%
1-Month 0.15% 0.35% -0.75%
1-Year 151.14% 176.88% 61.82%
3-Year CAGR 17.13% -3.35% 18.16%
5-Year CAGR 17.42% 10.98% 19.79%

* Compound Annual Growth Rate

Here are more details on the Lupin share price and the STRIDES PHARMA SCIENCE share price.

Moving on to shareholding structures...

The promoters of Lupin hold a 47.0% stake in the company. In case of STRIDES PHARMA SCIENCE the stake stands at 27.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Lupin and the shareholding pattern of STRIDES PHARMA SCIENCE.

Finally, a word on dividends...

In the most recent financial year, Lupin paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 40.7%.

STRIDES PHARMA SCIENCE paid Rs 1.5, and its dividend payout ratio stood at -5.9%.

You may visit here to review the dividend history of Lupin, and the dividend history of STRIDES PHARMA SCIENCE.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.